By Topic

Hemodynamic management of congestive heart failure by means of a multiple mode rule-based control system using fuzzy logic

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Held, C.M. ; Dept. of Biomed. Eng., Rensselaer Polytech. Inst., Troy, NY, USA ; Roy, Rob J.

A rule-based system was designed to control the mean arterial pressure (MAP) and the cardiac output (GO) of a patient with congestive heart failure (CHF), using two vasoactive drugs; sodium nitroprusside (SNP) and dopamine (DPM). The controller has three different modes, that engage according to the hemodynamic state. The critical conditions control mode (CCC) determines the initial infusion rates, and continues active if the MAP or the CO fall outside of the defined critically thresholds: an upper and a lower boundary for the MAP and a lower boundary for the CO. Inside the boundaries the control is performed by noncritical conditions control modes (NCC's), which are fuzzy logic controllers. If the CO is within normal range and the MAP is close to the goal range, then the MAP is driven using only SNP, in a single-input-single-output mode (NCC-SISO). Otherwise the NCC multiple input-multiple-output is active (NCC-MIMO). The goal values for the controlled variables are defined as a band of 5 mmHg for the MAP and 5 mL/kg/min for the CO, but there is little concern for this application if the CO is too high (i.e., in practical terms the CO only needs to achieve a necessary minimum rate). The NCC-MIMO includes a gain adaptation algorithm to cope with the wide variety in sensitivities to SNP. Supervisory capabilities to ensure adequate drug delivery complete the controller scheme. After extensive testing and tuning on a CHF-hemodynamics nonlinear model, the control system was applied in dog experiments, which led to further enhancements. The results show an adequate control, presenting a fast response to setpoint changes with an acceptable overshoot.

Published in:

Biomedical Engineering, IEEE Transactions on  (Volume:47 ,  Issue: 1 )